Hello,
Any ideas why 2 of the patients had a rapid response to rituximab at six weeks in the 2009 Fluge/Melle paper, but this type of rapid response wasn't seen in the subsequent studies?
https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-28
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
Thanks.
Any ideas why 2 of the patients had a rapid response to rituximab at six weeks in the 2009 Fluge/Melle paper, but this type of rapid response wasn't seen in the subsequent studies?
https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-28
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
Thanks.